Novo Nordisk A/S Class B (0QIU)

636.20
+6.00(+0.95%)
  • Volume:
    545,587
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    636.20 - 636.20

0QIU Overview

Prev. Close
630.2
Day's Range
636.2-636.2
Revenue
-
Open
611.8
52 wk Range
420.35-773.2
EPS
-
Volume
545,587
Market Cap
1.47T
Dividend (Yield)
9.35
(1.46%)
Average Volume (3m)
575,653
P/E Ratio
31.40
Beta
-
1-Year Change
40.16%
Shares Outstanding
2,277,263,279
Next Earnings Date
02 Feb 2022
What is your sentiment on Novo Nordisk A/S Class B?
or
Market is currently closed. Voting is open during market hours.

Novo Nordisk A/S Class B Company Profile

Employees
46982
Market
Denmark

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyNeutralBuy
Technical IndicatorsNeutralNeutralStrong BuyStrong SellStrong Buy
SummaryNeutralNeutralStrong BuySellStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.